Reduced CMRO2 and cerebrovascular reserve in patients with severe intracranial arterial stenosis: A combined multiparametric qBOLD oxygenation and BOLD fMRI study

Human Brain Mapping

Volumn 36, Issue 2, 2015, Pages 695-706

  Bouvier, Julien ^a,b,c   Detante, Olivier ^a,b,d   Tahon, Florence ^d   Attye, Arnaud ^d   Perret, Thomas ^a,b   Chechin, David ^c   Barbieux, Marianne ^a,b,d   Boubagra, Kamel ^d   Garambois, Katia ^d   Tropres, Irène ^b   Grand, Sylvie ^a,b,d   Barbier, Emmanuel L ^a,b   Krainik, Alexandre ^a,b,d  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b UNIV GRENOBLE ALPES   (France)

^c PHILIPS RESEARCH LABORATORIES   (Germany)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

BOLD fMRI; Brain; Cerebral metabolic rate of oxygen (CMRO2); Cerebrovascular reserve; Hypercapnia; Intracranial arterial stenosis; Microvasculature; Perfusion; Stroke; Tissular oxygen saturation (StO2)

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD OXYGENATION; BOLD SIGNAL; BRAIN ISCHEMIA; BRAIN MAPPING; CEREBRAL METABOLIC RATE OF OXYGEN; CLINICAL ARTICLE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; HYPERCAPNIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCLUSIVE CEREBROVASCULAR DISEASE; OXYGEN SATURATION; PRIORITY JOURNAL; BLOOD; BRAIN; BRAIN ANGIOGRAPHY; BRAIN CIRCULATION; CEREBRAL ARTERY DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

OXYGEN;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN MAPPING; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; INTRACRANIAL ARTERIAL DISEASES; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; SEVERITY OF ILLNESS INDEX;

EID: 84922235682     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22657     Document Type: Article

References (54)

1. An H, Lin W (2000): Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab 20:1225-1236.
2. An H, Lin W, Celik A, Lee YZ (2001): Quantitative measurements of cerebral metabolic rate of oxygen utilization using MRI: A volunteer study. NMR Biomed 14:441-447.
3. Attye A, Villien M, Tahon F, Warnking J, Detante O, Krainik A (2014): Normalization of cerebral vasoreactivity using BOLD MRI after intravascular stenting. Hum Brain Mapp 35:1320-1324.
4. Baron JC, Jones T (2012): Oxygen metabolism, oxygen extraction and positron emission tomography: Historical perspective and impact on basic and clinical neuroscience. NeuroImage 61:492-504.
5. Blicher JU, Stagg CJ, O'Shea J, Ostergaard L, MacIntosh BJ, Johansen-Berg H, Jezzard P, Donahue MJ (2012): Visualization of altered neurovascular coupling in chronic stroke patients using multimodal functional MRI. J Cerebral Blood Flow Metab 32:2044-2054.
6. Blockley NP, Griffeth VE, Buxton RB (2012): A general analysis of calibrated BOLD methodology for measuring CMRO2 responses: Comparison of a new approach with existing methods. NeuroImage 60:279-289.
7. Bouvier J, Detante O, Tropres I, Grand S, Chechin D, Le Bas J-F, Krainik A, Barbier EL (2013): Evaluation of a multiparamteric qBOLD approach in acute stroke patients. ISMRM. Salt Lake City, Etats-Unis.
8. Bulte D, Chiarelli P, Wise R, Jezzard P (2007): Measurement of cerebral blood volume in humans using hyperoxic MRI contrast. J Magn Reson Imaging 26:894-899.
9. 2 in Alzheimer's disease using BOLD fMRI. NeuroImage 58:579-587.
10. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ, SAMMPRIS Trial Investigators (2011): Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993-1003.
11. Christen T, Lemasson B, Pannetier N, Farion R, Segebarth C, Remy C, Barbier EL (2011): Evaluation of a quantitative blood oxygenation level-dependent (qBOLD) approach to map local blood oxygen saturation. NMR Biomed 24:393-403.
12. Christen T, Lemasson B, Pannetier N, Farion R, Remy C, Zaharchuk G, Barbier EL (2012a): Is T2* enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor. Radiology 262:495-502.
13. Christen T, Schmiedeskamp H, Straka M, Bammer R, Zaharchuk G (2012b): Measuring brain oxygenation in humans using a multiparametric quantitative blood oxygenation level dependent MRI approach. Magn Reson Med 68:905-911.
14. Christen T, Zaharchuk G, Pannetier N, Serduc R, Joudiou N, Vial JC, Remy C, Barbier EL (2012c): Quantitative MR estimates of blood oxygenation based on T2*: A numerical study of the impact of model assumptions. Magn Reson Med 67:1458-1468.
15. Christen T, Bouzat P, Pannetier N, Coquery N, Moisan A, Lemasson B, Thomas S, Grillon E, Detante O, Remy C, Payen JF, Barbier EL (2014): Tissue oxygen saturation mapping with magnetic resonance imaging. J Cereb Blood Flow Metab 34:1550-1557.
16. Christen T, Ni W, Qiu D, Schmiedeskamp H, Bammer R, Moseley M, Zaharchuk G: High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol. Magn Reson Med. 2012 Sep 21. doi: 10.1002/mrm.24500. [Epub ahead of print]
17. Conklin J, Fierstra J, Crawley AP, Han JS, Poublanc J, Silver FL, Tymianski M, Fisher JA, Mandell DM, Mikulis DJ (2011): Mapping white matter diffusion and cerebrovascular reactivity in carotid occlusive disease. Neurology 77:431-438.
18. Derdeyn CP, Grubb RL Jr, Powers WJ (1999): Cerebral hemodynamic impairment: Methods of measurement and association with stroke risk. Neurology 53:251-259.
19. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG (2007): US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke 38:881-887.
20. Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J (1994): Altered cerebral energy metabolism in Alzheimer's disease: A PET study. J Nucl Med 35:1-6.
21. Grubb RL Jr, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, Spitznagel EL, Powers WJ (1998): Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 280:1055-1060.
22. Haller S, Bonati LH, Rick J, Klarhofer M, Speck O, Lyrer PA, Bilecen D, Engelter ST, Wetzel SG (2008): Reduced cerebrovascular reserve at CO2 BOLD MR imaging is associated with increased risk of periinterventional ischemic lesions during carotid endarterectomy or stent placement: Preliminary results. Radiology 249:251-258.
23. Han JS, Abou-Hamden A, Mandell DM, Poublanc J, Crawley AP, Fisher JA, Mikulis DJ, Tymianski M (2011): Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 42:3047-3054.
24. He X, Yablonskiy DA (2007): Quantitative BOLD: Mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: Default state. Magn Reson Med 57:115-126.
25. Heyn C, Poublanc J, Crawley A, Mandell D, Han JS, Tymianski M, terBrugge K, Fisher JA, Mikulis DJ (2010): Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease. Am J Neuroradiol 31:862-867.
26. Hokari M, Kuroda S, Shiga T, Nakayama N, Tamaki N, Iwasaki Y (2008): Combination of a mean transit time measurement with an acetazolamide test increases predictive power to identify elevated oxygen extraction fraction in occlusive carotid artery diseases. J Nucl Med 49:1922-1927.
27. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L, LADIS Study Group (2009): Changes in white matter as determinant of global functional decline in older independent outpatients: Three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 339:b2477.
28. Ishii K, Sasaki M, Kitagaki H, Sakamoto S, Yamaji S, Maeda K (1996): Regional difference in cerebral blood flow and oxidative metabolism in human cortex. J Nucl Med 37:1086-1088.
29. Jensen-Kondering U, Baron JC (2012): Oxygen imaging by MRI: Can blood oxygen level-dependent imaging depict the ischemic penumbra? Stroke 43:2264-2269.
30. Jiang Z, Krainik A, David O, Salon C, Tropres I, Hoffmann D, Pannetier N, Barbier EL, Bombin ER, Warnking J, Pasteris C, Chabardes S, Berger F, Grand S, Segebarth C, Gay E, Le Bas JF (2010): Impaired fMRI activation in patients with primary brain tumors. NeuroImage 52:538-548.
31. Krainik A, Hund-Georgiadis M, Zysset S, von Cramon DY (2005): Regional impairment of cerebrovascular reactivity and BOLD signal in adults after stroke. Stroke 36:1146-1152.
32. Krainik A, Villien M, Tropres I, Attye A, Lamalle L, Bouvier J, Pietras J, Grand S, Le Bas JF, Warnking J (2013): Functional imaging of cerebral perfusion. Diagn Interv Imaging 94:1259-1278.
33. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H (2001): Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: Can acetazolamide test predict it? Stroke 32:2110-2116.
34. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, American Heart Association Statistics Committee, Stroke Statistics Subcommittee (2009): Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:480-486.
35. Mandell DM, Han JS, Poublanc J, Crawley AP, Stainsby JA, Fisher JA, Mikulis DJ (2008): Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in patients with arterial steno-occlusive disease: Comparison with arterial spin labeling MRI. Stroke 39:2021-2028.
36. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F (2006): Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA study. Neurology 66:1187-1191.
37. Meier P, Zierler KL (1954): On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 6:731-744.
38. Nemoto EM, Yonas H, Chang Y (2003): Stages and thresholds of hemodynamic failure. Stroke 34:2-3.
39. Nemoto EM, Yonas H, Kuwabara H, Pindzola RR, Sashin D, Meltzer CC, Price JC, Chang Y, Johnson DW (2004): Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab 24:1081-1089.
40. Nguyen-Huynh MN, Wintermark M, English J, Lam J, Vittinghoff E, Smith WS, Johnston SC (2008): How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke 39:1184-1188.
41. Ogasawara K, Ogawa A, Yoshimoto T (2002): Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: A xenon-133 single-photon emission computed tomography study. Stroke 33:1857-1862.
42. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996): High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 36:715-725.
43. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000): A standardized method for measuring intracranial arterial stenosis. Am J Neuroradiol 21:643-646.
44. Seiler A, Jurcoane A, Magerkurth J, Wagner M, Hattingen E, Deichmann R, Neumann-Haefelin T, Singer OC (2012): T2' imaging within perfusion-restricted tissue in high-grade occlusive carotid disease. Stroke 43:1831-1836.
45. 2 blood oxygen level-dependent MR mapping of cerebrovascular reserve in a clinical population: Safety, tolerability, and technical feasibility. Radiology 266:592-598.
46. Stefanovic B, Pike GB (2005): Venous refocusing for volume estimation: VERVE functional magnetic resonance imaging. Magn Reson Med 53:339-347.
47. Stewart GN (1893): Researches on the circulation time in organs and on the influences which affect it: Parts I-III. J Physiol 15:1-89.
48. Tanaka M, Shimosegawa E, Kajimoto K, Kimura Y, Kato H, Oku N, Hori M, Kitagawa K, Hatazawa J (2008): Chronic middle cerebral artery occlusion: A hemodynamic and metabolic study with positron-emission tomography. Am J Neuroradiol 29:1841-1846.
49. Tatu L, Moulin T, Vuillier F, Bogousslavsky J (2012): Arterial territories of the human brain. Front Neurol Neurosci 30:99-110.
50. West J (2007): Pulmonary Physiology and Pathophysiology: An Integrated, Case-Based Approach. Philadelphia, PA: Lippincott Williams & Wilkins.
51. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG (2003): Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 50:164-174.
52. Xie S, Hui LH, Xiao JX, Zhang XD, Peng Q (2011): Detecting misery perfusion in unilateral steno-occlusive disease of the internal carotid artery or middle cerebral artery by MR imaging. Am J Neuroradiol 32:1504-1509.
53. Yablonskiy DA, Haacke EM (1994): Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime. Magn Reson Med 32:749-763.
54. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, Konishi J, Shio H (1999): Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 40:1992-1998.